SomaLogic, Inc. (NASDAQ:SLGC) Q3 2022 Earnings Conference Call November 14, 2022 8:30 AM ET

Company Participants

Marissa Bych - Investor Relations, Gilmartin Group LLC

Roy Smythe - Chief Executive Officer

Shaun Blakeman - Chief Financial Officer

Conference Call Participants

Kyle Mikson - Canaccord Genuity

Evan Stampler - Stifel

Dan Brennan - Cowen

Operator

Good morning, and welcome to SomaLogic's Third Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. We will be facilitating a question-and-answer session towards the end of today's call. As a reminder, this call is being recorded for replay purposes.

I would now like to turn the call over to Marissa Bych with Gilmartin Group Investor Relations for introductory comments.

Marissa Bych

Thank you. Today, SomaLogic released financial results for the quarter ended September 30, 2022. A copy of the press release is available on the company's website. Before we begin, I'd like to remind you that management will make forward-looking statements during this call within the meaning of federal securities laws, which are made pursuant to the Safe Harbor Provision of the Private Securities Litigation Reform Act of 1995.

Any statements contained in this call that relates to expectations or predictions of future events, results, or performance are forward-looking statements. All forward-looking statements, including without limitation, those relating to our market opportunity, gross margin, and future financial performance, protein content, and database growth, customer base, diagnostic pipeline, expectations for hiring, and growth in our organization are based upon our current estimates and various assumptions.

These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied by these forward-looking statements.

Accordingly, you should not place undue reliance on these statements for a list and description of the risks and uncertainties associated with our business, please refer to the Risk Factors section of our most recent Form 10-Q filed with the Securities and Exchange Commission and a section entitled Risk Factors in our most recent annual report on Form 10-K.

This conference call contains time-sensitive information and is actuate only as of the live broadcast today, November 14, 2022. SomaLogic disclaims any intention or obligation, except as required by law, to update or revise any financial projections or forward-looking statements, whether because of new information, future events, or otherwise.

And with that, I will turn the call over to Roy Smythe, Chief Executive Officer.